Why a Pregnancy Tdap Shot Protects the Newborn
Whooping cough, or pertussis, can be especially dangerous in very young infants. A newborn has not yet had time to build protection through their own vaccine series, and the illness can cause severe breathing problems. The Tdap vaccine—protecting against tetanus, diphtheria, and pertussis—helps bridge that vulnerable period when given during pregnancy.
The Placenta Transfers a Temporary Defense
After vaccination, the pregnant person’s immune system makes antibodies: proteins that recognize and help fight germs. In the third trimester, some of those antibodies pass through the placenta into the fetus’s bloodstream. The baby is born with this borrowed protection, which can help during the first weeks and months of life.
This is passive protection: the infant receives ready-made antibodies rather than producing them through their own immune response. It fades over time, so it complements rather than replaces the baby’s routine vaccinations.
What Refusal Changes
Declining Tdap during pregnancy means missing the vaccine-induced boost in pertussis antibodies that could otherwise be transferred to the fetus. It does not mean the newborn has no defenses at all, but it removes an important way to provide protection before the infant can be vaccinated. The practical consequence is a more exposed early window—when a cough that may seem ordinary in an older person can become a serious illness for a newborn.
